Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2009-3-3
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1552-4833
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
149A
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
552-4
pubmed:dateRevised
2009-4-17
pubmed:meshHeading
pubmed-meshheading:19215053-Animals, pubmed-meshheading:19215053-Cell Line, pubmed-meshheading:19215053-Cell Membrane, pubmed-meshheading:19215053-Culture Media, Conditioned, pubmed-meshheading:19215053-Fluorescein-5-isothiocyanate, pubmed-meshheading:19215053-Fluorescent Antibody Technique, Direct, pubmed-meshheading:19215053-Fluorescent Dyes, pubmed-meshheading:19215053-Genes, Reporter, pubmed-meshheading:19215053-Genetic Vectors, pubmed-meshheading:19215053-Glypicans, pubmed-meshheading:19215053-Hedgehog Proteins, pubmed-meshheading:19215053-Humans, pubmed-meshheading:19215053-Kidney, pubmed-meshheading:19215053-Luciferases, pubmed-meshheading:19215053-Male, pubmed-meshheading:19215053-Mice, pubmed-meshheading:19215053-NIH 3T3 Cells, pubmed-meshheading:19215053-Point Mutation, pubmed-meshheading:19215053-Proteoglycans, pubmed-meshheading:19215053-Signal Transduction, pubmed-meshheading:19215053-Syndrome, pubmed-meshheading:19215053-Time Factors, pubmed-meshheading:19215053-Transfection, pubmed-meshheading:19215053-beta-Galactosidase
pubmed:year
2009
pubmed:articleTitle
A patient with the Simpson-Golabi-Behmel syndrome displays a loss-of-function point mutation in GPC3 that inhibits the attachment of this proteoglycan to the cell surface.
pubmed:affiliation
Division of Molecular and Cellular Biology, Sunnybrook Health Sciences Centre, Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
pubmed:publicationType
Journal Article, Case Reports, Research Support, Non-U.S. Gov't